HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Akio Oishi Selected Research

peanut agglutinin receptor

11/2006Identification of the decay-accelerating factor CD55 as a peanut agglutinin-binding protein and its alteration in non-small cell lung cancers.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Akio Oishi Research Topics

Disease

31Macular Degeneration (Age-Related Maculopathy)
06/2022 - 04/2011
16Polypoidal Choroidal Vasculopathy
12/2019 - 04/2011
10Atrophy
06/2022 - 01/2013
10Retinitis Pigmentosa (Pigmentary Retinopathy)
01/2021 - 07/2009
7Choroidal Neovascularization
11/2018 - 01/2012
5Myopia
04/2016 - 01/2012
4Lung Neoplasms (Lung Cancer)
01/2013 - 12/2003
3Ischemic Optic Neuropathy (Anterior Ischemic Optic Neuropathy)
01/2020 - 01/2014
3Neurodegenerative Diseases (Neurodegenerative Disease)
09/2018 - 06/2008
3Neoplasms (Cancer)
08/2013 - 06/2005
2Disease Progression
01/2021 - 06/2015
2Retinal Perforations
06/2019 - 01/2017
2Epiretinal Membrane (Epiretinal Membranes)
06/2019 - 04/2012
2Retinal Detachment (Retinal Detachments)
05/2019 - 05/2013
2Retinal Diseases
01/2019 - 11/2012
2Cone-Rod Dystrophies
01/2018 - 01/2013
2Geographic Atrophy
01/2016 - 02/2013
2Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung)
06/2015 - 06/2005
1Polyps
01/2021
1Optic Nerve Diseases (Optic Neuropathy)
01/2020
1Vitelliform Macular Dystrophy
01/2020
1Retinoschisis (Retinoschisis, Juvenile)
06/2019
1Blister (Bulla)
05/2019
1White Dot Syndromes
04/2019
1Necrosis
02/2019
1Strabismus (Squint)
10/2018
1Vitreous Hemorrhage
01/2017
1Noninfiltrating Intraductal Carcinoma (DCIS)
08/2016
1Eye Diseases (Eye Disease)
01/2016
1Interstitial Lung Diseases (Interstitial Lung Disease)
06/2015
1Fundus Albipunctatus
03/2014
1Telangiectasis (Telangiectasia)
06/2013
1Retinal Dystrophies
01/2013
1Leber Congenital Amaurosis
01/2013
1Neuroinflammatory Diseases
11/2012
1Macular Edema
08/2012
1Blindness (Hysterical Blindness)
01/2012
1Cataract (Cataracts)
04/2011
1Vascular Diseases (Vascular Disease)
01/2011
1Retinal Neovascularization
07/2009
1Retinal Degeneration
06/2008

Drug/Important Bio-Agent (IBA)

19Retinaldehyde (Retinal)IBA
01/2021 - 01/2012
16Ranibizumab (Lucentis)FDA Link
11/2021 - 01/2012
14Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA
06/2022 - 11/2011
11afliberceptIBA
11/2021 - 11/2014
71-phenyl-3,3-dimethyltriazene (PDT)IBA
06/2022 - 07/2011
5Complement Factor H (Factor H)IBA
11/2019 - 02/2012
4Retinal Pigments (Pigments, Visual)IBA
01/2018 - 01/2016
3Verteporfin (Visudyne)FDA Link
06/2022 - 10/2013
2SteroidsIBA
04/2019 - 06/2015
2Indocyanine Green (Cardio-Green)FDA LinkGeneric
01/2019 - 03/2013
2Fluorescein (Funduscein)FDA LinkGeneric
01/2019 - 06/2013
2Neuroprotective AgentsIBA
09/2018 - 01/2012
2DNA (Deoxyribonucleic Acid)IBA
01/2016 - 01/2013
2ras-GRF1 (ras GRF1)IBA
10/2014 - 11/2013
2Granulocyte Colony-Stimulating Factor (G-CSF)IBA
01/2011 - 06/2008
1Pharmaceutical PreparationsIBA
01/2020
1Type II Vasoactive Intestinal Peptide ReceptorsIBA
11/2019
1Immunosuppressive Agents (Immunosuppressants)IBA
04/2019
1Cyclosporine (Ciclosporin)FDA LinkGeneric
04/2019
1Adrenal Cortex Hormones (Corticosteroids)IBA
04/2019
1Adalimumab (Humira)FDA Link
04/2019
1Interleukin-8 (Interleukin 8)IBA
02/2019
1Interleukin-6 (Interleukin 6)IBA
02/2019
1Interleukin-10 (Interleukin 10)IBA
02/2019
1Vascular Endothelial Growth FactorsIBA
09/2018
1ErbB Receptors (EGF Receptor)IBA
06/2015
1Erlotinib Hydrochloride (CP 358,774)FDA Link
06/2015
1Tyrosine Kinase InhibitorsIBA
06/2015
1Retinoic Acid 4-Hydroxylase (CYP26B1)IBA
10/2014
1Semaphorins (Semaphorin)IBA
07/2014
1LipidsIBA
09/2013
1Cholesterol Ester Transfer ProteinsIBA
09/2013
1AutoantibodiesIBA
08/2013
1Bevacizumab (Avastin)FDA Link
01/2013
1CC ChemokinesIBA
11/2012
1Chemokine CCL2 (Monocyte Chemoattractant Protein 1)IBA
11/2012
1FibrinIBA
08/2012
1Complement Factor B (Factor B)IBA
02/2012
1Complement C2 (Complement Component 2)IBA
02/2012
1pigment epithelium-derived factorIBA
07/2011
1Complement C1 (Complement 1)IBA
04/2011
1Complement C1 Inhibitor Protein (C1 Esterase Inhibitor)IBA
04/2011
1Triamcinolone (Aristocort)FDA Link
07/2009
1ErythropoietinFDA Link
06/2008
1CytokinesIBA
06/2008

Therapy/Procedure

12Therapeutics
06/2022 - 06/2007
8Intravitreal Injections
12/2019 - 01/2013
7Photochemotherapy (Photodynamic Therapy)
06/2022 - 07/2011
5Injections
01/2018 - 11/2011
3Lasers (Laser)
03/2014 - 01/2013
2Traction
06/2019 - 04/2016
2Vitrectomy
05/2019 - 01/2017
1Subcutaneous Injections
04/2019
1Telescopes
10/2018
1Drug Therapy (Chemotherapy)
06/2015
1Segmental Mastectomy (Lumpectomy)
01/2013
1Thoracotomy
01/2013
1Transjugular Intrahepatic Portasystemic Shunt
04/2012
1Retreatment
07/2011